Transplantable delivery systems for in situ controlled release of bisphosphonate in orthopedic therapy

Bibliography

• Russell RGG, Watts NB, Ebetino FH, Rogers MJ. Mechanisms of action of bisphosphonates: Similarities and differences and their potential influence on clinical efficacy. Osteoporos Int 2008;19(6):733-59
   PubMed Web of Science ®Google Scholar
• Luckman SP, Hughes DE, Coxon FP, Nitrogen-containing bisphosphonates inhibit the mevalonate pathway and prevent post-translational prenylation of GTP-binding proteins, including Ras. J Bone Miner Res 1998;13(4):581-9
   PubMed Web of Science ®Google Scholar
• Grazio S, Babic-Naglic D, Kehler T, Curkovic B. Persistence of weekly alendronate: a real-world study in Croatia. Clin Rheumatol 2008;27(5):651-3
   PubMed Web of Science ®Google Scholar
• Delaney MF, Hurwitz S, Shaw J, LeBoff MS. Bone density changes with once weekly risedronate in postmenopausal women. J Clin Densitom 2003;6(1):45-50
   PubMed Web of Science ®Google Scholar
• Kiagia M, Karapanagiotou E, Charpidou A, Rapid infusion of ibandronate in lung cancer patients with bone metastases. Anticancer Res 2006;26(4 B):3133-6
   PubMedGoogle Scholar
• Grey A, Bolland MJ, Wattie D, The antiresorptive effects of a single dose of zoledronate persist for two years: a randomized, placebo-controlled trial in osteopenic postmenopausal women. J Clin Endocrinol Metab 2009;94(2):538-44
   PubMed Web of Science ®Google Scholar
• Body JJ. Clinical research update: zoledronate. Cancer 1997;80(8 Suppl):1699-701
   PubMed Web of Science ®Google Scholar
• Green JR, Rogers MJ. Pharmacologic profile of zoledronic acid: a highly potent inhibitor of bone resorption. Drug Dev Res 2002;55(4):210-24
   Web of Science ®Google Scholar
• Coleman RE. Bisphosphonates in breast cancer. Annals Oncol 2005;16(5):687-95
   PubMed Web of Science ®Google Scholar
• Black DM, Delmas PD, Eastell R, Once-yearly zoledronic acid for treatment of postmenopausal osteoporosis. N Engl J Med 2007;356(18):1809-22
   PubMed Web of Science ®Google Scholar
• Rauch F, Glorieux FH. Osteogenesis imperfecta, current and future medical treatment. Am J Med Genet Semin Med Genet 2005;139C(1):31-7
   PubMed Web of Science ®Google Scholar
• Borah B, Ritman EL, Dufresne TE, The effect of risedronate on bone mineralization as measured by micro-computed tomography with synchrotron radiation: correlation to histomorphometric indices of turnover. Bone 2005;37(1):1-9
   PubMed Web of Science ®Google Scholar
• Little DG, McDonald M, Sharpe IT, Zoledronic acid improves femoral head sphericity in a rat model of perthes disease. J Orthop Res 2005;23(4):862-8
   PubMed Web of Science ®Google Scholar
• Russell RGG, Rogers MJ. Bisphosphonates: from the laboratory to the clinic and back again. Bone 1999;25(1):97-106
   PubMed Web of Science ®Google Scholar
• Ezra A, Golomb G. Administration routes and delivery systems of bisphosphonates for the treatment of bone resorption. Adv Drug Deliv Rev 2000;42(3):175-95
   PubMed Web of Science ®Google Scholar
• Nancollas GH, Tang R, Phipps RJ, Novel insights into actions of bisphosphonates on bone: differences in interactions with hydroxyapatite. Bone 2006;38(5):617-27
   PubMed Web of Science ®Google Scholar
• Lanza F, Sahba B, Schwartz H, The upper GI safety and tolerability of oral alendronate at a dose of 70 milligrams once weekly: a placebo-controlled endoscopy study. Am J Gastroenterol 2002;97(1):58-64
   PubMed Web of Science ®Google Scholar
• Woo SB, Hellstein JW, Kalmar JR. Systematic review: bisphosphonates and osteonecrosis of the jaws. Ann Int Med 2006;144(10):753-61
   PubMed Web of Science ®Google Scholar
• Josse S, Faucheux C, Soueidan A, Novel biomaterials for bisphosphonate delivery. Biomaterials 2005;26(14):2073-80
   PubMed Web of Science ®Google Scholar
• Peter B, Gauthier O, Laib S, Local delivery of bisphosphonate from coated orthopedic implants increases implants mechanical stability in osteoporotic rats. J Biomed Mater Res – Part A 2006;76(1):133-43
   PubMed Web of Science ®Google Scholar
• Palazzo B, Iafisco M, Laforgia M, Biomimetic hydroxyapatite-drug nanocrystals as potential bone substitutes with antitumor drug delivery properties. Adv Funct Mater 2007;17(13):2180-8
   Web of Science ®Google Scholar
• Samdancioglu S, Calis S, Sumnu M, Hincal AA. Formulation and in vitro evaluation of bisphosphonate loaded microspheres for implantation in osteolysis. Drug Dev Ind Pharm 2006;32(4):473-81
   PubMed Web of Science ®Google Scholar
• Nafea EH, El-Massik MA, El-Khordagui LK, Alendronate PLGA microspheres with high loading efficiency for dental applications. J Microencapsul 2007;24(6):525-38
   PubMed Web of Science ®Google Scholar
• Shi X, Wang Y, Ren L, Enhancing alendronate release from a novel PLGA/hydroxyapatite microspheric system for bone repairing applications. Pharm Res 2009;26(2):422-30
   PubMed Web of Science ®Google Scholar
• Sutton SC, Engle K, Fix JA. Intranasal delivery of the bisphosphonate alendronate in the rat and dog. Pharm Res 1993;10(6):924-6
   PubMed Web of Science ®Google Scholar
• Duncan AR. The use of subcutaneous pamidronate. J Pain Symptom Manage 2003;26(1):592-3
   PubMed Web of Science ®Google Scholar
• Conte P, Guarneri V. Safety of intravenous and oral bisphosphonates and compliance with dosing regimens. Oncologist 2004;9(Suppl 4):28-37
   PubMed Web of Science ®Google Scholar
• Adami S, Zamberlan N. Adverse effects of bisphosphonates: a comparative review. Drug Saf 1996;14(3):158-70
   PubMed Web of Science ®Google Scholar
• Kresge CT, Leonowicz ME, Roth WJ, Ordered mesoporous molecular sieves synthesized by a liquid-crystal template mechanism. Nature 1992;359(6397):710-12
   Web of Science ®Google Scholar
• Inagaki S, Fukushima Y, Kuroda K. Synthesis of highly ordered mesoporous materials from a layered polysilicate. J Chem Soc Chem Commun 1993(8):680-2
   Google Scholar
• Balas F, Manzano M, Horcajada P, Vallet-Regi M. Confinement and controlled release of bisphosphonates on ordered mesoporous silica-based materials. J Am Chem Soc 2006;128(25):8116-17
   PubMed Web of Science ®Google Scholar
• Nieto A, Balas F, Colilla M, Functionalization degree of SBA-15 as key factor to modulate sodium alendronate dosage. Microporous Mesoporous Mater 2008;116(1-3):4-13
   Web of Science ®Google Scholar
• Nieto A, Colilla M, Balas F, Vallet-Regi M. Surface electrochemistry of mesoporous silicas as a key factor in the design of tailored delivery devices. Langmuir 2010;26(7):5038-49
   PubMed Web of Science ®Google Scholar
• Colilla M, Izquierdo-Barba I, Vallet-Regi M. Phosphorus-containing SBA-15 materials as bisphosphonate carriers for osteoporosis treatment. Microporous Mesoporous Mater 2010;135(1-3):51-9
   Web of Science ®Google Scholar
• Colilla M, Manzano M, Izquierdo-Barba I, Advanced drug delivery vectors with tailored surface properties made of mesoporous binary oxides submicronic spheres. Chem Mater 2010;22(5):1821-30
   Web of Science ®Google Scholar
• Daculsi G, Bouler JM, Legeros RZ. Adaptive crystal formation in normal and pathological calcifications in synthetic calcium phosphate and related biomaterials. Int Rev Cytol 1997;172:129-91
   PubMed Web of Science ®Google Scholar
• LeGeros RZ. Calcium phosphates in oral biology and medicine. Monogr oral sci 1991;15:1-201
   PubMedGoogle Scholar
• Rush SM. Bone graft substitutes: osteobiologics. Clin Podiatr Med Surg 2005;22(4):619-30
   PubMedGoogle Scholar
• Vallet-Regi M. Revisiting ceramics for medical applications. Dalton Trans 2006(44):5211-20
   PubMed Web of Science ®Google Scholar
• Matsumoto T, Okazaki M, Inoue M, Hydroxyapatite particles as a controlled release carrier of protein. Biomaterials 2004;25(17):3807-12
   PubMed Web of Science ®Google Scholar
• Oliveira AL, Pedro AJ, Saiz Arroyo C, Biomimetic Ca-P coatings incorporating bisphosphonates produced on starch-based degradable biomaterials. J Biomed Mater Res Part B Appl Biomater 2010;92(1):55-67
   PubMed Web of Science ®Google Scholar
• Faucheux C, Verron E, Soueidan A, Controlled release of bisphosphonate from a calcium phosphate biomaterial inhibits osteoclastic resorption in vitro. J Biomed Mater Res Part A 2009;89(1):46-56
   PubMed Web of Science ®Google Scholar
• Russell RGG, Croucher PI, Rogers MJ. Bisphosphonates: pharmacology, mechanisms of action and clinical uses. Osteoporos Int 1999;9:S66-S80
   PubMed Web of Science ®Google Scholar
• Kamoi K, Yoneyama T, Nishizawa K, Application of bone grafts to periodontal therapy. 1. Material and biological studies on hydroxyapatite. Nippon Shishubyo Gakkai kaishi 1984;26(2):275-88
   PubMedGoogle Scholar
• Seshima H, Yoshinari M, Takemoto S, Control of bisphosphonate release using hydroxyapatite granules. Journal of Biomed Mater Res Part B Appl Biomater 2006;78(2):215-21
   PubMed Web of Science ®Google Scholar
• Iafisco M, Palazzo B, Marchetti M, Smart delivery of antitumoral platinum complexes from biomimetic hydroxyapatite nanocrystals. J Mater Chem 2009;19(44):8385-92
   Web of Science ®Google Scholar
• Boanini E, Gazzano M, Rubini K, Bigi A. Composite nanocrystals provide new insight on alendronate interaction with hydroxyapatite structure. Adv Mater 2007;19(18):2499-502
   Web of Science ®Google Scholar
• Bigi A, Boanini E, Capuccini C, Biofunctional alendronate-Hydroxyapatite thin films deposited by matrix assisted pulsed laser evaporation. Biomaterials 2009;30(31):6168-77
   PubMed Web of Science ®Google Scholar
• Roussiere H, Fayon F, Alonso B, Reaction of zoledronate with beta-tricalcium phosphate for the design of potential drug device combined systems. Chem Mater 2008;20(1):182-91
   Web of Science ®Google Scholar
• Ong HT, Loo JSC, Boey FYC, Exploiting the high-affinity phosphonate-hydroxyapatite nanoparticle interaction for delivery of radiation and drugs. J Nanoparticle Res 2008;10(1):141-50
   Web of Science ®Google Scholar
• McLeod K, Anderson GI, Dutta NK, Adsorption of bisphosphonate onto hydroxyapatite using a novel co-precipitation technique for bone growth enhancement. J Biomed Mater Res Part A 2006;79(2):271-81
   PubMed Web of Science ®Google Scholar
• Fernandez E, Gil FJ, Ginebra MP, Calcium phosphate bone cements for clinical applications. Part II: precipitate formation during setting reactions. J Mater Sci: Mater Med 1999;10(3):177-83
   PubMed Web of Science ®Google Scholar
• Bigi A, Panzavolta S, Rubini K. Setting mechanism of a biomimetic bone cement. Chem Mater 2004;16(19):3740-5
   Web of Science ®Google Scholar
• Ginebra MP, Rilliard A, Fernndez E, Mechanical and rheological improvement of a calcium phosphate cement by the addition of a polymeric drug. J Biomed Mater Res 2001;57(1):113-18
   PubMed Web of Science ®Google Scholar
• Schnitzler V, Fayon F, Despas C, Investigation of alendronate-doped apatitic cements as a potential technology for the prevention of osteoporotic hip fractures: critical influence of the drug introduction mode on the in vitro cement properties. Acta Biomaterialia 2010; doi:10.1016/j.actbio.2010.09.017
   Google Scholar
• Panzavolta S, Torricelli P, Bracci B, Alendronate and pamidronate calcium phosphate bone cements: setting properties and in vitro response of osteoblast and osteoclast cells. J Inorg Biochem 2009;103(1):101-6
   PubMed Web of Science ®Google Scholar
• Giocondi JL, El-Dasher BS, Nancollas GH, Orme CA. Molecular mechanisms of crystallization impacting calcium phosphate cements. Philos Trans R Soc A: Math Phys Eng Sci 2010;368(1917):1937-61
   Web of Science ®Google Scholar
• Epstein H, Berger V, Levi I, Nanosuspensions of alendronate with gallium or gadolinium attenuate neointimal hyperplasia in rats. J Control Release 2007;117(3):322-32
   PubMed Web of Science ®Google Scholar
• Cohen-Sela E, Chorny M, Koroukhov N, A new double emulsion solvent diffusion technique for encapsulating hydrophilic molecules in PLGA nanoparticles. J Control Release 2009;133(2):90-5
   PubMed Web of Science ®Google Scholar
• Perugini P, Genta I, Conti B, Long-term release of clodronate from biodegradable microspheres. AAPS PharmSciTech [electronic resource] 2001;2(3):E10
   Google Scholar
• Yaffe A, Herman A, Bahar H, Binderman I. Combined local application of tetracycline and bisphosphonate reduces alveolar bone resorption in rats. J Periodontol 2003;74(7):1038-42
   PubMed Web of Science ®Google Scholar
• Wiedenauer U, Bodmer D, Kissel T. Microencapsulation of hydrophilic drug substances using biodegradable polyesters. Part I: evaluation of different techniques for the encapsulation of Pamidronate di-sodium salt. J Microencapsul 2003;20(4):509-24
   PubMed Web of Science ®Google Scholar
• Weidenauer U, Bodmer D, Kissel T. Microencapsulation of hydrophilic drug substances using biodegradable polyesters. Part II: implants allowing controlled drug release – A feasibility study using bisphosphonates. J Microencapsul 2004;21(2):137-49
   PubMed Web of Science ®Google Scholar
• Shi X, Wang Y, Varshney RR, In-vitro osteogenesis of synovium stem cells induced by controlled release of bisphosphate additives from microspherical mesoporous silica composite. Biomaterials 2009;30(23-24):3996-4005
   PubMed Web of Science ®Google Scholar
• Billon-Chabaud A, Gouyette A, Merle C, Bouler JM. Development of bisphosphonates controlled delivery systems for bone implantation: influence of the formulation and process used on in vitro release. J Mater Sci: Mater Med 2010;21(5):1599-604
   PubMed Web of Science ®Google Scholar
• Gautier H, Merle C, Auget JL, Daculsi G. Isostatic compression, a new process for incorporating vancomycin into biphasic calcium phosphate: comparison with a classical method. Biomaterials 2000;21(3):243-9
   PubMed Web of Science ®Google Scholar
• Healey JH, Shannon F, Boland P, DiResta GR. PMMA to stabilize bone and deliver antineoplastic and antiresorptive agents. Clin Orthop Relat Res 2003;Oct(415 Suppl):S263-S275
   Google Scholar
• Horowitz SM, Algan SA, Purdon MA. Pharmacologic inhibition of particulate-induced bone resorption. J Biomedi Mater Res 1996;31(1):91-6
   PubMed Web of Science ®Google Scholar
• Lewis G, Janna S. Alendronate in bone cement: fatigue life degraded by liquid, not by powder. Clin Orthop Relat Res 2006(445):233-8
   PubMed Web of Science ®Google Scholar
• Sabokbar A, Fujikawa Y, Murray DW, Athanasou NA. Bisphosphonates in bone cement inhibit PMMA particle induced bone resorption. Ann Rheum Dis 1998;57(10):614-18
   PubMed Web of Science ®Google Scholar
• Rodriguez-Lorenzo LM, Fernandez M, Parra J, Acrylic injectable and self-curing formulations for the local release of bisphosphonates in bone tissue. J Biomed Mater Res Part B Appl Biomater 2007;83(2):596-608
   PubMed Web of Science ®Google Scholar
• Zenios M, Nokes L, Galasko CSB. Effect of a bisphosphonate, disodium pamidronate, on the quasi-static flexural properties of Palacos R acrylic bone cement. J Biomed Mater Res Part B Appl Biomater 2004;71(2):322-6
   PubMed Web of Science ®Google Scholar
• Yu NYC, Ruys AJ, Zenios M, Bisphosphonate-laden acrylic bone cement: mechanical properties, elution performance, and in vivo activity. J Biomed Mater Res Part B Appl Biomater 2008;87(2):482-91
   PubMed Web of Science ®Google Scholar
• Varghese OP, Sun W, Hilborn J, Ossipov DA. In situ cross-linkable high molecular weight hyaluronan-bisphosphonate conjugate for localized delivery and cell-specific targeting: a hydrogel linked prodrug approach. J Am Chem Soc 2009;131(25):8781-3
   PubMed Web of Science ®Google Scholar
• Doschak MR, Kucharski CM, Wright JEI, Improved bone delivery of osteoprotegerin by bisphosphonate conjugation in a rat model of osteoarthritis. Mol Pharm 2009;6(2):634-40
   PubMed Web of Science ®Google Scholar
• Liu XM, Lee HT, Reinhardt RA, Novel biomineral-binding cyclodextrins for controlled drug delivery in the oral cavity. J Control Release 2007;122(1):54-62
   PubMed Web of Science ®Google Scholar
• Astrand J, Aspenberg P. Topical, single dose bisphosphonate treatment reduced bone resorption in a rat model for prosthetic loosening. J Orthop Res 2004;22(2):244-9
   PubMed Web of Science ®Google Scholar
• Yaffe A, Binderman I, Breuer E, Disposition of alendronate following local delivery in a rat jaw. J Periodontol 1999;70(8):893-5
   PubMed Web of Science ®Google Scholar
• Tengvall P, Skoglund B, Askendal A, Aspenberg P. Surface immobilized bisphosphonate improves stainless-steel screw fixation in rats. Biomaterials 2004;25(11):2133-8
   PubMed Web of Science ®Google Scholar
• Aya-Ay J, Athavale S, Morgan-Bagley S, Retention, distribution, and effects of intraosseously administered ibandronate in the infarcted femoral head. J Bone Miner Res 2007;22(1):93-100
   PubMed Web of Science ®Google Scholar
• Greiner S, Kadow-Romacker A, Wildemann B, Bisphosphonates incorporated in a poly(D,L-lactide) implant coating inhibit osteoclast like cells in vitro. J Biomed Mater Res Part A 2007;83(4):1184-91
   PubMed Web of Science ®Google Scholar
• Cenni E, Granchi D, Avnet S, Biocompatibility of poly(D,L-lactide-co-glycolide) nanoparticles conjugated with alendronate. Biomaterials 2008;29(10):1400-11
   PubMed Web of Science ®Google Scholar
• Peter B, Pioletti DP, Laib S, Calcium phosphate drug delivery system: influence of local zoledronate release on bone implant osteointegration. Bone 2005;36(1):52-60
   PubMed Web of Science ®Google Scholar
• Meraw SJ, Reeve CM, Wollan PC. Use of alendronate in peri-implant defect regeneration. J Periodontol 1999;70(2):151-8
   PubMed Web of Science ®Google Scholar
• Stadelmann VA, Gauthier O, Terrier A, Implants delivering bisphosphonate locally increase periprosthetic bone density in an osteoporotic sheep model. A pilot study. Eur Cell Mater 2008;16:10-6
   PubMed Web of Science ®Google Scholar
• Verron E, Gauthier O, Janvier P, In vivo bone augmentation in an osteoporotic environment using bisphosphonate-loaded calcium deficient apatite. Biomaterials 2010;31(30):7776-84
   PubMed Web of Science ®Google Scholar
• Binderman I, Adut M, Yaffe A. Effectiveness of local delivery of alendronate in reducing alveolar bone loss following periodontal surgery in rats. J Periodontol 2000;71(8):1236-40
   PubMed Web of Science ®Google Scholar
• Yaffe A, Golomb G, Breuer E, Binderman I. The effect of topical delivery of novel bisacylphosphonates in reducing alveolar bone loss in the rat model. J Periodontol 2000;71(10):1607-12
   PubMed Web of Science ®Google Scholar
• Kaynak D, Meffert R, Gunhan M, A histopathological investigation on the effects of the bisphosphonate alendronate on resorptive phase following mucoperiosteal flap surgery in the mandible of rats. J Periodontol 2000;71(5):790-6
   PubMed Web of Science ®Google Scholar
• Yaffe A, Iztkovich M, Earon Y, Local delivery of an amino bisphosphonate prevents the resorptive phase of alveolar bone following mucoperiosteal flap surgery in rats. J Periodontol 1997;68(9):884-9
   PubMed Web of Science ®Google Scholar
• Levin L, Bryson EC, Caplan D, Trope M. Effect of topical alendronate on root resorption of dried replanted dog teeth. Dental Traumatol 2001;17(3):120-6
   PubMed Web of Science ®Google Scholar
• Fournier P, Boissier S, Filleur S, Bisphosphonates inhibit angiogenesis in vitro and testosterone-stimulated vascular regrowth in the ventral prostate in castrated rats. Cancer Res 2002;62(22):6538-44
   PubMed Web of Science ®Google Scholar
• Nagai T, Imai H, Honda S, Negi A. Antiangiogenic effects of bisphosphonates on laser-induced choroidal neovascularization in mice. Investig Ophthalmol Vis Sci 2007;48(12):5716-21
   PubMed Web of Science ®Google Scholar
• Wood J, Bonjean K, Ruetz S, Novel antiangiogenic effects of the bisphosphonate compound zoledronic acid. J Pharmacol Exp Ther 2002;302(3):1055-61
   PubMed Web of Science ®Google Scholar
• Lambrinoudaki I, Christodoulakos G, Botsis D. Bisphosphonates. Ann NY Acad Sci 2006;1092:397-402
   PubMed Web of Science ®Google Scholar
• Denissen H, Van Beek E, Martinetti R, Net-shaped hydroxyapatite implants for release of agents modulating periodontal-like tissues. J Periodontal Res 1997;32(1 PART 1):40-6
   PubMed Web of Science ®Google Scholar
• Piattelli A, Scarano A, Mangano C. Clinical and histologic aspects of biphasic calcium phosphate ceramic (BCP) used in connection with implant placement. Biomaterials 1996;17(18):1767-70
   PubMed Web of Science ®Google Scholar
• Yu H, Qin A. Could local delivery of bisphosphonates be a new therapeutic choice for hemangiomas? Med Hypotheses 2009;73(4):495-7
   PubMed Web of Science ®Google Scholar
• Pignatello R, Cenni E, Micieli D, A novel biomaterial for osteotropic drug nanocarriers: synthesis and biocompatibility evaluation of a PLGA-ALE conjugate. Nanomedicine 2009;4(2):161-75
   PubMed Web of Science ®Google Scholar
• Truong SV, Chang LC, Berger TG. Bisphosphonate-related osteonecrosis of the jaw presenting as a cutaneous dental sinus tract: a case report and review of the literature. J Am Acad Dermatology 2010;62(4):672-6
   PubMed Web of Science ®Google Scholar